Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 30, 2016 - Issue 23
131
Views
8
CrossRef citations to date
0
Altmetric
Short Communications

Investigation of in vitro cytotoxic, mutagenic and anti-mutagenic effects of shirazolide extracted from Jurinea leptoloba

&
Pages 2743-2746 | Received 16 Oct 2015, Accepted 24 Dec 2015, Published online: 17 Feb 2016
 

Abstract

Shirazolide is an elemanolide isolated from Jurinea leptoloba DC. The aim of this study was to determine the cytotoxic, mutagenic and anti-mutagenic properties of shirazolide from J. leptoloba DC in vitro. Cytotoxicity was measured using a modified MTT (3-(4,5-di methyl thiazol-2-yl)-2,5-di phenyltetrazolium bromide) assay on normal human lymphocytes and tumor HeLa cells, showing that the cytotoxicity of shirazolide is much higher for HeLa cells than for normal lymphocytes. Mutagenic and anti-mutagenic activities of shirazolide were evaluated using the Salmonella typhimurium tester strains TA98 and TA100 showing anti-mutagenic properties against the former strain under metabolic activation.

Acknowledgements

. I would like to thank sincerely Dr Iraj Rasooli in the medicinal plant research center of Shahed University for scientific assistance. The authors would like to thank sincerely Dr Mozaffarian for assistance in the botanical information.

Funding

This study was supported by Islamic Azad University’s (Takestan Branch) Research Deputy Office [grant number TIAU: 50155].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.